Our experimental results also suggested that silencing MDM2 mimics the tumor-suppressive activity of miR-590-3p in HepG2 cells, indicating that miR-590-3p plays a tumor-suppressor role in HepG2 by targeting MDM2. The gene discussed is MDM2; the disease is neoplasm.